SEC Filing Details
Document Details
Form
Filing Date
Mar 30, 2018
Document Date
Mar 22, 2018
Form Description
Initial filing by director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
Bellerophon Therapeutics, Inc.
Issuer
BELLEROPHON THERAPEUTICS, INC.
Filer
BENNETT MATTHEW